Information  X 
Enter a valid email address

Citigroup GM Fdg Lux (IRSH)

  Print      Mail a friend

Monday 17 June, 2019

Citigroup GM Fdg Lux

Article 8

RNS Number : 3245C
Citigroup Global Markets Fdg Lux
17 June 2019
 

NOTICE

pursuant to the Final Terms dated 18 April 2019 as amended and restated by the Amended and Restated Final Terms dated 12 June 2019 (the Final Terms)

relating to

Citigroup Global Markets Funding Luxembourg S.C.A.

Issue of up to GBP 5,000,000 Citigroup Global Markets Funding Luxembourg S.C.A. Notes due June 2027 linked to Preference Shares of Citigroup Global Markets Funding Luxembourg S.C.A. Series CGMFL6895

 

Guaranteed by Citigroup Global Markets Limited

Under the Citi U.S.$60,000,000,000 Global Medium Term Note Programme

 

(Series Number: CGMFL6895, ISIN: XS1980038084)

 

The Issuer hereby provides notice in accordance with the Final Terms that:

(a)        the final Aggregate Principal Amount of the Notes to be issued on 14 June 2019 will be GBP 274,000;

(b)        the title of the Notes is now "Issue of GBP 274,000 Citigroup Global Markets Funding Luxembourg S.C.A. Notes due June 2027 linked to Preference Shares of Citigroup Global Markets Funding Luxembourg S.C.A. Series CGMFL6895"; and

(c)        the final distribution fee payable to the Authorised Offeror in respect of the Notes to be issued on 14 June 2019 will be 1.09 per cent. of the Aggregate Principal Amount.

 

Capitalised terms used but not defined herein shall be as defined in the Final Terms.

 

This Notice and the Final Terms shall be read and construed together as one document.

 

 

 

 

 

 

 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEEAPKLFSXNEEF

a d v e r t i s e m e n t